RESUMO
ABSTRACT: Objectives consist of updating published reports on the recognition, assessment, and care of patients with Wernicke-Korsakoff syndrome (WKS). Methods included defining relevant terms, describing core clinical phenomena, conducting meaningful reviews for latter-day WKS publications, and selecting instructive case examples. Findings covered epidemiology, precipitants, neuroimaging studies, alternate learning strategies in WKS, adjunctive treatments, and promising research. In conclusion, patients, their family members, clinicians, and public health experts should benefit from this updated knowledge. Countries with substantial alcohol consumption should consider emulating Holland in designating WKS research centers, founding regional clinical facilities, and funding multidisciplinary expert teams.
Assuntos
Síndrome de Korsakoff/diagnóstico , Síndrome de Korsakoff/fisiopatologia , Síndrome de Korsakoff/terapia , HumanosRESUMO
Releases of aquatic organisms-in-trade by aquarists, water gardeners, and outdoor pond owners have been identified as aquatic invasive species vectors within the Laurentian Great Lakes region. The trademarked U.S. Fish and Wildlife Service Habitattitude campaign was developed in 2004 to encourage self-regulation by these groups, but little is known about its effects. We surveyed organisms-in-trade hobbyists in the eight Great Lakes states (Illinois, Indiana, Michigan, Minnesota, New York, Ohio, Pennsylvania, and Wisconsin, USA) to assess their recognition of the Habitattitude campaign and their compliance with the campaign's recommended behaviors for organism purchase and disposal. Awareness of the Habitattitude campaign was low, but hobbyists that identified as both water gardeners and aquarium hobbyists were more aware of the campaign than individuals who participated in one of those hobbies. Engaged hobbyists (high aquatic invasive species awareness, concern, and knowledge) were significantly more likely than passive hobbyists (low aquatic invasive species awareness, concern, and knowledge) to make decisions about disposal of live organisms with the intention of preventing aquatic invasive species spread, were more likely to contact other hobbyists for disposal and handling advice, and were less likely to contact professionals, such as retailers. On the basis of our results, we suggest that compliance with recommended behaviors may be increased by fostering hobbyist networks; creating materials that both explain tangible, negative environmental impacts and list specific prevention behaviors; and disseminating these materials through trusted information sources and venues.
Assuntos
Organismos Aquáticos/crescimento & desenvolvimento , Atitude , Conservação dos Recursos Naturais/métodos , Passatempos , Espécies Introduzidas/tendências , Animais , Relações Comunidade-Instituição , Conservação dos Recursos Naturais/tendências , Peixes/crescimento & desenvolvimento , Great Lakes Region , Passatempos/psicologia , Humanos , Illinois , Indiana , Michigan , Minnesota , New York , Ohio , Pennsylvania , Estados Unidos , WisconsinRESUMO
Objective: The effectiveness of antidepressant treatment for mood disorders is often limited by either a poor response or the emergence of adverse effects. These complications often necessitate multiple drug trials. This clinical challenge intensifies during pregnancy, when medications must be selected to improve the likelihood of response and optimize reproductive outcomes. We determined the distribution of common pharmacogenetic variants, metabolizer phenotypes, past medication responses, and side effects in childbearing-aged individuals seeking treatment in a tertiary care perinatal mental health clinic.Methods: Sixty treatment-seeking women (based on sex at birth) with DSM-5- defined bipolar disorder (n = 28) or major depressive disorder (n = 32) provided DNA samples and completed psychiatric diagnostic and severity assessments between April 2014 and December 2017. Samples were genotyped for single-nucleotide variants in drug metabolizing enzyme genes of commonly prescribed antidepressants (cytochrome P450 [CYP] 1A2, 2B6, 2C9, 2C19, 2D6, 3A4, and 3A5), and the frequency of normative metabolizer status was compared to reference populations data from Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines. The Antidepressant Treatment History Form was used to record historic medication trials and side effects.Results: A significantly greater proportion of extensive metabolizers for CYP2B6 was observed in the study population when compared to CPIC population frequency databases in Caucasians (0.64 vs 0.43 [95% CI: 0.49-0.76]; P value = .006) and African Americans (0.71 vs 0.33 [95% CI: 0.29-0.96]; P value = .045). No significant association was found between metabolizer phenotype and the likelihood of a medication side effect.Conclusion: Pharmacogenomic testing may have value for personalized prescribing in individuals capable of or considering pregnancy.
Assuntos
Antidepressivos , Transtorno Bipolar , Transtorno Depressivo Maior , Humanos , Feminino , Adulto , Transtorno Depressivo Maior/tratamento farmacológico , Transtorno Depressivo Maior/genética , Antidepressivos/uso terapêutico , Antidepressivos/efeitos adversos , Antidepressivos/farmacocinética , Gravidez , Transtorno Bipolar/tratamento farmacológico , Transtorno Bipolar/genética , Adulto Jovem , Atenção Terciária à Saúde , Polimorfismo de Nucleotídeo Único , Assistência Perinatal , Complicações na Gravidez/tratamento farmacológico , Complicações na Gravidez/genética , Centros de Atenção Terciária , Variantes Farmacogenômicos , FarmacogenéticaRESUMO
Objective: The primary purpose of this article is to identify factors that are associated with worsening mood and anxiety trajectories across the perinatal period among pregnant individuals receiving treatment with a selective-serotonin reupdate inhibitor. Methods: This secondary analysis of primary data from the original article, Trajectories of Depressive and Anxiety Symptoms Across Pregnancy and Postpartum in Selective Serotonin Reuptake Inhibitor-Treated Women, explores if number of lifetime episodes of depression as characterized in the Mini-International Neuropsychiatric Interview, elevated maternal adverse childhood experiences (ACE) score, or specific obstetric or neonatal factors from the Peripartum Events Scale (PES) were associated with membership in trajectory groups with the highest symptom burden. Results: No difference in ACE scores or obstetric or neonatal factors were associated with membership in the trajectory groups using Wilcoxon rank sum tests and bi-variable logistic regression. The trajectory group with the highest anxiety symptom burden experienced more lifetime episodes of depression compared to other groups (odds ratio = 1.17, 95% confidence intervals, 1.02-1.34, p = 0.03). Conclusions: Congruent with other studies, we found a high prevalence of co-occurring mood and anxiety symptoms and that past episodes of depression remain an important historical risk factor for perinatal symptom burden. This reinforces that past experiences of depression increase not only the risk of future symptoms but also higher symptom burden during antidepressant treatment.
RESUMO
Antibody discovery against complex antigens is limited by the availability of a reproducible pure source of concentrated properly folded antigen. We have developed a technology to enable direct incorporation of membrane proteins such as GPCRs and into the membrane of poxvirus. The protein of interest is correctly folded and expressed in the cell-derived viral membrane and does not require any detergents or refolding before downstream use. The poxvirus is selective in which proteins are incorporated into the viral membrane, making the antigen poxvirus an antigenically cleaner target for in vitro panning. Antigen-expressing virus can be readily purified at scale and used for antibody selection using any in vitro display platform.
Assuntos
Antígenos , Biblioteca de Peptídeos , Anticorpos , Proteínas de Membrana , Membrana CelularRESUMO
Mothers of infants in the NICU suffer higher rates of psychological distress, anxiety, and depression compared with the general population. Often, their mental health concerns remain underidentified and undertreated, which can have deleterious effects on the offspring, both in short-term outcomes while in the NICU as well as long-term neurodevelopmental and behavioral outcomes. In this review, we present an overview of existing empirical evidence about how maternal mental health affects the health of infants, special considerations regarding the mental health needs of NICU mothers, and the findings about existing and developing interventions to address mental health concerns in this vulnerable population.